Stichting World Duchenne Organization

Stichting World Duchenne Organization is an organisation in Veenendaal, Netherlands that has taken part in 8 EU-funded projects since 2016, receiving €1.5M in EU funding.

EU funding received€1.5M
EU projects8
As coordinator0
Running now3
First EU project2016
Latest project2024
CountryNetherlands
EU registration (PIC)930321860
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Stichting World Duchenne Organization's own share of each project, not the project's full budget.

  • Horizon 2020€1.4M · 5 projects
  • Horizon Europe€97k · 2 projects
  • 3rd Health Programme€0 · 1 project

Projects

8 EU-funded projects, newest first. Each links to the official record.

  • ERDERAPartner

    EUROPEAN RARE DISEASES RESEARCH ALLIANCE

    Horizon Europe · 2024–2031 · Project on CORDIS ↗

    €97ktheir share
  • REGENERATE-ITAssociated partner

    Learning from animals how to regenerate: multidisciplinary training programme in regenerative biology

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • BEAMERPartner

    BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €266ktheir share
  • EURO-NMD RegistryPartner

    Patient centered and interoperable registry hub for Rare Neuromuscular Diseases

    3rd Health Programme · 2020–2023 · Project on the EU portal ↗

  • BINDPartner

    Brain Involvement iN Dystrophinopathies

    Horizon 2020 · 2020–2024 · Project on CORDIS ↗

    €166ktheir share
  • Trials@HomePartner

    Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

    €436ktheir share
  • SHARE4RAREPartner

    Social media platform dedicated to rare diseases, using collective intelligence for the generation of awareness and advanced knowledge on this large group of diseases.

    Horizon 2020 · 2018–2021 · Project on CORDIS ↗

    €183ktheir share
  • VISION DMDPartner

    VISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €340ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • artificial intelligence
  • civil society
  • deep learning
  • duchenne muscular dystrophy
  • ecosystems
  • genetics
  • health care services
  • invertebrate zoology
  • mutation
  • natural language processing
  • neurobiology
  • proteins
  • public health
  • stem cells

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime